e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Comorbidities and respiratory disease and late-breaking abstracts
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of medicines and prevalence of co-morbid diseases in subjects with and without COPD in Sweden
S. A. Jansson, H. Backman, E. Rönmark, B. Lundbäck, A. Lindberg (Luleå, Umeå, Gothenburg, Sweden)
Source:
Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Session:
Comorbidities and respiratory disease and late-breaking abstracts
Session type:
Poster Discussion
Number:
3450
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. A. Jansson, H. Backman, E. Rönmark, B. Lundbäck, A. Lindberg (Luleå, Umeå, Gothenburg, Sweden). Use of medicines and prevalence of co-morbid diseases in subjects with and without COPD in Sweden. Eur Respir J 2013; 42: Suppl. 57, 3450
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Comorbidity in patients with IHD - the prevalence of COPD
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Comorbidities, gender-differences and COPD severity: The French Palomb cohort
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Comorbidities and COPD severity: The French Palomb cohort
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Co-morbidities of COPD in primary care
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
Comorbidity in patients with COPD in Russia
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Prevalence of COPD in vascular diseases
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Comorbidities and burden of COPD: A population based case-control study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014
Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Prevalence of chronic kidney disease (CKD) in the UK COPD population
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Prevalence and incidence of COPD: The Rotterdam study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Co-morbidity is the main cost driver among COPD-subjects
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept